Jesús Moreno-Fernández1, José Alberto García-Seco2, Elena María Ortega Rodrigo3, Angela María Seco Segura2, Fernando García-Seco4, José Ramón Muñoz-Rodríguez5. 1. Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. Electronic address: jmorenof@sescam.jccm.es. 2. Endocrinology and Nutrition Department, Ciudad Real University Hospital, Ciudad Real, Spain. 3. Ciudad Real Medicine School, Castilla-La Mancha University, Ciudad Real, Spain. 4. Córdoba Medicine School, Córdoba University, Córdoba, Spain. 5. Translational Research Unit, Ciudad Real University Hospital, Ciudad Real, Spain.
Abstract
AIM: To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients. MATERIALS AND METHODS: Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status. RESULTS: Three hundred patients were analyzed (male 53%). Mean age was 40.0±14.4years and T1DM duration was 19.7±11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up. CONCLUSIONS: The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
AIM: To document adherence to influenza, pneumococcal and hepatitis B virus (HBV) vaccination programme in adult type 1 diabetes mellitus (T1DM) patients. MATERIALS AND METHODS: Observational retrospective study using data obtained from computerized clinical records. We contacted all adult T1DM registered in our database from a tertiary diabetes care hospital. Primary efficacy outcome was to describe influenza, pneumococcal and HBV vaccination status. RESULTS: Three hundred patients were analyzed (male 53%). Mean age was 40.0±14.4years and T1DM duration was 19.7±11.8years. Thirty-five percent of the patients had complementary indications for studied vaccines. Adherence to vaccination program for influenza, pneumococcal and HBV was achieved by 55%, 18% and 17% of the patients, respectively. Only 3% of the subjects were vaccinated against the three microorganisms. Predictor of correct vaccination were: age, shorter diabetes duration, insulin pump treatment, better diabetes control and being a health professional. We detected 17 sick leaves, 127 lost working days and 3 hospitalizations due to flue during the follow-up. CONCLUSIONS: The uptake of recommended vaccinations against influenza, pneumococcal and HBV in adult T1DM patients was below desirable levels. A special effort is required to all health professionals to implement immunization among adult people with T1DM. Clinical Trials NCT03478254.
Authors: Jose J Zamorano-Leon; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Javier de-Miguel-Diez; David Carabantes-Alarcon; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; Khaoula Zekri-Nechar; Sara Sanz-Rojo Journal: J Clin Med Date: 2021-12-23 Impact factor: 4.241
Authors: Georgios Galanos; Helen Dimitriou; Angelos Pappas; Chrysoula Perdikogianni; Emmanouil K Symvoulakis; Emmanouil Galanakis; Christos Lionis Journal: Front Public Health Date: 2022-08-01